{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Label+Comprehension&page=2", "query": { "condition": "Label Comprehension", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Label+Comprehension&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-23T07:23:23.817Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07508228", "title": "A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male Adults", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Oral [14C]PF-07328948", "type": "DRUG" }, { "name": "Oral Unlabeled PF-07328948", "type": "DRUG" }, { "name": "IV [14C]PF-07328948", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "MALE", "summary": "18 Years to 64 Years · Male only" }, "enrollment_count": 8, "start_date": "2026-04-03", "completion_date": "2026-09-24", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT07508228" }, { "nct_id": "NCT02842073", "title": "An Open Label Trial of Bupropion and Naltrexone for Binge Drinking", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Binge Drinking" ], "interventions": [ { "name": "Naltrexone", "type": "DRUG" }, { "name": "Bupropion", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "34 Years", "sex": "ALL", "summary": "21 Years to 34 Years" }, "enrollment_count": 12, "start_date": "2016-11-01", "completion_date": "2017-12-13", "has_results": true, "last_update_posted_date": "2018-12-26", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02842073" }, { "nct_id": "NCT06698796", "title": "A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dermatomyositis", "Polymyositis" ], "interventions": [ { "name": "Dazukibart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 211, "start_date": "2025-01-22", "completion_date": "2027-11-25", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 4, "location_summary": "Glendale, Arizona • Allen, Texas • Houston, Texas + 1 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Allen", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Beckley", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06698796" }, { "nct_id": "NCT07253441", "title": "A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Attention Deficit Disorder With Hyperactivity" ], "interventions": [ { "name": "CTN XR (TBM)", "type": "DRUG" }, { "name": "CTN SR", "type": "DRUG" }, { "name": "CTN XR (Clin)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 174, "start_date": "2024-08-29", "completion_date": "2024-12-30", "has_results": false, "last_update_posted_date": "2025-12-11", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 2, "location_summary": "Lenexa, Kansas • Millcreek, Utah", "locations": [ { "city": "Lenexa", "state": "Kansas" }, { "city": "Millcreek", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07253441" }, { "nct_id": "NCT07214805", "title": "Perceptions of and Reactions to Ultra-Processed Menu Label Designs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Food Choices" ], "interventions": [ { "name": "Ultra-Processed, Red, Icon-plus-text Labels", "type": "BEHAVIORAL" }, { "name": "Contains Food Additives, Red, Icon-plus-text Labels", "type": "BEHAVIORAL" }, { "name": "Warning Ultra-Processed, Red, Icon-plus-text Labels", "type": "BEHAVIORAL" }, { "name": "Warning UPF, Red, Icon-plus-text Labels", "type": "BEHAVIORAL" }, { "name": "Ultra-Processed, Yellow, Icon-plus-text Labels", "type": "BEHAVIORAL" }, { "name": "Contains Food Additives, Yellow, Icon-plus-text Labels", "type": "BEHAVIORAL" }, { "name": "Warning Ultra-Processed, Yellow, Icon-plus-text Labels", "type": "BEHAVIORAL" }, { "name": "Warning UPF, Yellow, Icon-plus-text Labels", "type": "BEHAVIORAL" }, { "name": "Ultra-Processed, Red, Text-only Labels", "type": "BEHAVIORAL" }, { "name": "Contains Food Additives, Red, Text-only Labels", "type": "BEHAVIORAL" }, { "name": "Warning Ultra-Processed, Red, Text-only Labels", "type": "BEHAVIORAL" }, { "name": "Warning UPF, Red, Text-only Labels", "type": "BEHAVIORAL" }, { "name": "Ultra-Processed, Yellow, Text-only Labels", "type": "BEHAVIORAL" }, { "name": "Contains Food Additives, Yellow, Text-only Labels", "type": "BEHAVIORAL" }, { "name": "Warning Ultra-Processed, Yellow, Text-only Labels", "type": "BEHAVIORAL" }, { "name": "Warning UPF, Yellow, Text-only Labels", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14720, "start_date": "2025-10-09", "completion_date": "2025-11-02", "has_results": false, "last_update_posted_date": "2025-12-11", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07214805" }, { "nct_id": "NCT05648110", "title": "Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "COVID-19, SARS-CoV-2" ], "interventions": [ { "name": "AZD5156 (Parent study Sentinel Safety Cohort)", "type": "BIOLOGICAL" }, { "name": "Placebo (Parent study Sentinel Safety Cohort)", "type": "BIOLOGICAL" }, { "name": "EVUSHELD™ (Parent study Main Cohort)", "type": "BIOLOGICAL" }, { "name": "AZD3152 (Parent study Main Cohort)", "type": "BIOLOGICAL" }, { "name": "Placebo (Parent study Main Cohort)", "type": "BIOLOGICAL" }, { "name": "AZD3152 (Sub-study)", "type": "BIOLOGICAL" }, { "name": "AZD7442 - EVUSHELD™ (Sub-study)", "type": "BIOLOGICAL" }, { "name": "AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "12 Years to 130 Years" }, "enrollment_count": 3882, "start_date": "2022-12-16", "completion_date": "2025-02-11", "has_results": true, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 130, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Glendale, Arizona + 108 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05648110" }, { "nct_id": "NCT01310296", "title": "Lofexidine ADME & Mass Balance in Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product" ], "interventions": [ { "name": "Lofexidine hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "USWM, LLC (dba US WorldMeds)", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 12, "start_date": "2011-07", "completion_date": "2011-08", "has_results": false, "last_update_posted_date": "2017-10-26", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01310296" }, { "nct_id": "NCT05930925", "title": "A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "[phenyl-14C]ARV-471", "type": "DRUG" }, { "name": "[oxoisoindolin-14C]ARV-471", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2023-06-12", "completion_date": "2023-08-14", "has_results": false, "last_update_posted_date": "2026-06-02", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05930925" }, { "nct_id": "NCT05349864", "title": "A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "PF-07284890 Treatment A", "type": "DRUG" }, { "name": "PF-07284890 Treatment B", "type": "DRUG" }, { "name": "PF-07284890 Treatment C", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 12, "start_date": "2022-06-17", "completion_date": "2022-09-16", "has_results": true, "last_update_posted_date": "2024-03-15", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05349864" }, { "nct_id": "NCT05672745", "title": "How Phenotypical Characteristics of Woebot Users Are Related to Clinical Outcomes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "To Understand the Characteristics of Digital Mental Health Intervention Users as They Relate to Mental Health Outcomes" ], "interventions": [ { "name": "WB-LIFE", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Woebot Health", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 256, "start_date": "2022-05-11", "completion_date": "2022-07-23", "has_results": false, "last_update_posted_date": "2023-01-05", "last_synced_at": "2026-07-23T07:23:23.817Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05672745" } ] }